cancer and IBD

Question:

That’s consistent with my dr’s understanding…he says there are some very early indication that asacol may act as as deterrent as wella s a maintenance drug.  still being studied, but a real possibility.. – Hide quoted text — Show quoted text ->Deb, >Thanks for the posts. >The first article you link to give some very interesting info., esp. regarding CD.    It basically says that CD patients who have large bowel involvement have an increased risk for colorectal cancer (CRC) while those with just small bowel involvement have shown no evidence for an increased risk and no risk has yet to be reported.  It continues to confirm what I read in past literature for IBD, that the increase for UC and Crohn’s-Colitis patients increases after 8-10 years of severe disease. >What is interesting is when talking about prevention is that for CD patients when segments of colon are resected for other reasons it actually reduces the risk of CRC. There was also a statement suggesting that the use of 5ASA medicines could reduce the risk of CRC as well. >It is also interesting that intensive colonoscopy screening for CRC prevention is only recommended for those whose IBD has been in the colon for 8 years.  The intensive screening they define as multiple biopsies every 10 cm every 2-3 years.  This sounds much more civilized than what most GI’s seem to want.  We must also keep in mind that the success rates for CRC cures among IBD patients are extremely high because of the intensive screening we are under, when we comply with our doctors. >:)  mgbio > Preliminarily, this is what I have found. > Debs > PS They pretty much just group UC and Crohn’s together but they seem to > have a lot of good info that folks might like to read about, especially > the newer folks. > There’s this review: > http://216.239.41.104/search?q=cache:1EvB2qoTahgJ:www.medreviews.com/… > And this paper: > Review article: the incidence and prevalence of colorectal cancer in > inflammatory bowel disease > Alimentary Pharmacology & Therapeutics   September 2003, vol. 18, no. > s2,   pp. 1-5(5) > Munkholm P.[1] > [1] Department of Medical Gastroenterology, Hvidovre University > Hospital, Copenhagen, Denmark > Abstract: > Summary > Although colorectal cancer (CRC), complicating ulcerative colitis and > Crohn’s disease, only accounts for 1

Related Posts